Want to join the conversation?
$STT 1Q15 10-Q: In 1Q15, STT completed the $1.7Bil common stock purchase program authorized by the Board of Directors in March 2014 with the purchase of approx. 6.3MM shares of its common stock at an average per-share cost of $74.88 and an aggregate cost of approx. $470MM. In 1Q15, STT recorded acquisition costs of $5MM, compared to $21MM in 1Q14.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.